Tag Archive | "oropharyngeal cancer"

Henry Schein Donates Medical Supplies In Support of Free Oral Cancer Screening Events throughout the United States

Wednesday, July 27, 2016

0 Comments

Source: www.mysocialgoodnews.com Author: Api Potter Company’s Donation to Support 77 Screening Events in 2016 and 2017 by the Oral Cancer Foundation Press Release – MELVILLE, N.Y., July 25, 2016 – Henry Schein, Inc. (Nasdaq: HSIC) announced today that it is donating more than $10,000 in medical supplies to the Oral Cancer Foundation (OCF) in support of […]

Continue reading...

Knowledgeability, Attitude and Behavior of Primary Care Providers Towards Oral Cancer: a Pilot Study

Monday, July 25, 2016

0 Comments

Source: www.link.springer.com Authors: Neel Shimpi, Aditi Bharatkumar, Monica Jethwani, Po-Huang Cyou, Ingrid Glurich, Jake Blamer, Amit Acharya   The objective of this study was to assess current knowledgeability, attitudes, and practice behaviors of primary care providers (PCPs) towards oral cancer screening. Applying a cross-sectional design, a 14-question survey was emailed to 307 PCPs practicing at […]

Continue reading...

Aspen Dental Practices Donate More Than $20,000 To The Oral Cancer Foundation For Oral Cancer Awareness Month

Thursday, June 16, 2016

0 Comments

Source: www.pharmiweb.com.org Author: Aspen Dental   SYRACUSE, N.Y., May 31, 2016 /PRNewswire/ — Aspen Dental–branded practices will donate $22,375 to The Oral Cancer Foundation (OCF) as part of a program that contributed $5 for each ViziLite® oral cancer screening conducted during April for Oral Cancer Awareness Month. In total, more than 4,000 patients were screened across more […]

Continue reading...

Nivolumab Improved Survival For Patients With Head and Neck Squamous Cell Carcinoma

Tuesday, April 19, 2016

0 Comments

Source: www.aacr.org Author: AACR Newsroom Staff   NEW ORLEANS — Treatment with the immunotherapeutic nivolumab (Opdivo) improved survival for patients with recurrent or metastatic head and neck squamous cell carcinoma that progressed after platinum-based chemotherapy compared with single-agent chemotherapy of the investigator’s choice, according to results from the CheckMate-141 phase III clinical trial presented here […]

Continue reading...

The Oral Cancer Foundation’s Founder, Brian R. Hill, honored by the Global Oral Cancer Forum – International oral cancer community honor his accomplishments in the field.

Friday, March 11, 2016

0 Comments

Source: www.prnewswire.com Author: The Oral Cancer Foundation   NEWPORT BEACH, Calif., March 10, 2016 /PRNewswire-USNewswire/ — At the recent Global Oral Cancer Forum (GOCF), Brian R. Hill, Executive Director and Founder of the Oral Cancer Foundation (OCF), was honored for his work as an advocate and innovative thinker in the oral cancer arena. The GOCF organizers […]

Continue reading...

Immunotherapy Continues to Advance in Head and Neck Cancer

Monday, February 29, 2016

0 Comments

Source: www.onclive.com Author: Megan Garlapow, PhD   Concomitant administration of motolimod with cetuximab (Erbitux) increases the innate and adaptive immune response in the blood and the tumor microenvironment in head and neck squamous cell carcinoma (HNSCC), overcoming negative prognostic biomarkers of cetuximab therapy alone, according to the biomarker data from a recent phase Ib clinical […]

Continue reading...

NCCN Is ‘Vague,’ So Study Clarifies H&N Cancer Follow-up

Tuesday, February 23, 2016

0 Comments

Source: www.medscape.com Author: Nick Mulcahy   Clinical guidelines can sometimes be slow to respond to epidemiology. Take the case of oropharyngeal cancers that are associated with human papillomavirus (HPV) infection. They are increasingly common in the United States and, as several studies have demonstrated, have better survival than cancers of this type that are not […]

Continue reading...

Excitement at new cancer treatment

Monday, February 22, 2016

0 Comments

Source: www.news.doximity.com Author: James Gallagher A therapy that retrains the body’s immune system to fight cancer has provoked excitement after more than 90% of terminally ill patients reportedly went into remission.   White blood cells were taken from patients with leukaemia, modified in the lab and then put back. But the data has not been […]

Continue reading...

HPV vaccination rates are low, especially in Kansas and Missouri, and cancer experts are alarmed

Thursday, February 18, 2016

0 Comments

Source: www.kansascity.com Author: Lisa Gutierrez The HPV vaccine is recommended for girls and boys starting at ages 11 to 12. But in state-by-state comparisons, children in Kansas and Missouri rank at or near the bottom of the list. John Amis The Associated Press   The University of Kansas Cancer Center recently joined nearly 70 other […]

Continue reading...

HPV16 Antibodies Signal Even Better Oral Cancer Outcomes

Wednesday, June 17, 2015

0 Comments

Source: www.medscape.com Author: Neil Osterweil   Another prognostic tool may be in the offing for clinicians to use in evaluating patients with oropharyngeal cancers, new research suggests. The presence in serum of three antibodies to human papillomavirus type 16 (HPV16) was predictive of better progression-free and overall survival in these patients, according to Kristina R. […]

Continue reading...